Fact Sheet

COVID-19 Vaccine Research and Development

A teaser image displaying a portion of PhRMA's fact sheet on Covid-19 Vaccine Research and Development

As the COVID-19 pandemic continues to impact patients worldwide, America’s biopharmaceutical research companies are working around the clock with stakeholders across the research and development (R&D) ecosystem to advance vaccine candidates that will help prevent infection and stop the spread of the virus. In a matter of months, incredible progress has been made. The private sector has moved more than two dozen unique vaccines from initial R&D into preclinical testing and clinical trials.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.